Home/Filings/4/0001209191-20-033516
4//SEC Filing

Fordham Benjamin C 4

Accession 0001209191-20-033516

CIK 0001108109other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:23 PM ET

Size

13.2 KB

Accession

0001209191-20-033516

Insider Transaction Report

Form 4
Period: 2020-06-01
Fordham Benjamin C
EVP and General Counsel
Transactions
  • Tax Payment

    Common Stock

    2020-06-01$3.19/sh2,624$8,371197,383 total
Holdings
  • Stock Options (Right to Buy)

    Exercise: $4.99From: 2020-03-01Exp: 2029-02-28Common Stock (26,250 underlying)
    26,250
  • Stock Options (Right to Buy)

    Exercise: $4.93From: 2021-03-01Exp: 2030-02-28Common Stock (26,250 underlying)
    26,250
  • Performance Based Restricted

    Exercise: $0.00Common Stock (52,500 underlying)
    52,500
  • Performance Based Restricted

    Exercise: $0.00Common Stock (35,000 underlying)
    35,000
  • Performance Based Restricted

    Exercise: $0.00Common Stock (52,500 underlying)
    52,500
Footnotes (3)
  • [F1]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period.
  • [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
  • [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.

Issuer

COMMUNITY HEALTH SYSTEMS INC

CIK 0001108109

Entity typeother

Related Parties

1
  • filerCIK 0001700942

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:23 PM ET
Size
13.2 KB